Table of Contents
- Overview of Sodium Chloride in trials
- What these trials are testing
- Who is included
- Trial phases and study size
- Main outcomes being measured
- Selected important trials
- What this means for patients
Overview of Sodium Chloride in trials
Sodium Chloride appears in many studies as a placebo, a control, or a comparison fluid.[1] In these trials, the main question is usually about another treatment, procedure, or care strategy, not Sodium Chloride itself.[1]
The trial topics are very broad and include surgery, infection, pain, kidney disease, heart disease, lung disease, brain injury, and allergy testing.[1] Some studies also use Sodium Chloride as part of the study process in early safety research or in procedure-based trials.[1]
What these trials are testing
Many trials compare an active treatment against Sodium Chloride to see if the active treatment improves a health outcome.[1] Examples include pain control after surgery, infection prevention, recovery after critical illness, and changes in organ function.[1]
Pain and recovery studies look at things like opioid use, pain scores, mobility, and quality of recovery after surgery.[1]
Infection and inflammation studies look at outcomes such as mortality, infection rates, inflammatory markers, and time to clinical recovery.[1]
Organ function studies look at kidney, lung, heart, or brain outcomes, such as creatinine, forced vital capacity, ejection fraction, or neurological recovery.[1]
Procedure studies compare a treatment or technique with a placebo or sham procedure to see if it improves comfort, safety, or success of the procedure.[1]
Who is included
The target populations are very different from one trial to another.[1] Some studies include adults with chronic diseases such as cirrhosis, cancer, autoimmune disease, chronic pain, or kidney failure.[1]
Other studies focus on special groups such as children, newborns, adolescents, older adults, healthy volunteers, or patients in the intensive care unit (ICU).[1] Some trials also focus on people after surgery, such as cardiac surgery, hip surgery, colon surgery, or brain surgery.[1]
Several studies are aimed at very specific groups, such as people with severe hyponatremia, sickle cell disease, hidradenitis suppurativa, thyroid eye disease, or autism spectrum disorder.[1]
Trial phases and study size
The collection includes a wide mix of trial phases, with many studies in Phase 3 and several in Phase 2.[1] There are also smaller early studies in Phase 1 or Phase 1/2, and some low-intervention studies that mainly compare standard care or fluids.[1]
Enrollment ranges from very small pilot studies with fewer than 20 people to large multicenter trials with thousands of participants.[1] This shows that Sodium Chloride is used across both early research and larger confirmatory studies.[1]
Main outcomes being measured
The primary outcomes depend on the condition being studied and the goal of the trial.[1] Many outcomes are patient-centered, such as pain relief, breathing ability, mobility, recovery scores, or survival.[1]
Pain scores are used in many trials, often measured with scales such as the Numeric Rating Scale (NRS) or Visual Analog Scale (VAS).[1]
Recovery and function outcomes include walking, mobility scores, quality of recovery questionnaires, and disability scales.[1]
Organ injury or function outcomes include kidney injury, lung function, heart function, and brain injury markers.[1]
Safety outcomes often include adverse events, serious adverse events, laboratory tests, and vital signs.[1]
Some studies also use imaging tests, blood markers, or disease-specific scales to measure change over time.[1]
Selected important trials
The LOTUS trial studies chronic hemodialysis patients and looks at muscle protein synthesis and hemodynamic effects during a one-week treatment period.[1] Its main outcome is the difference in myofibrillar fractional synthetic rate, which is a measure of muscle protein building.[1]
The LIVER AKI trial compares human albumin with Sodium Chloride 0.9% in patients with decompensated cirrhosis and acute kidney injury, and it measures kidney recovery without the need for renal replacement therapy.[1] This is a Phase 3 study with 114 participants.[1]
The FORE-PAIN trial studies acute traumatic pain in the prehospital setting and compares several pain treatments against controls, including Sodium Chloride used intranasally and intravenously.[1] Its main outcome is the change in pain score 10 minutes after treatment.[1]
The CAT-Trial studies painful diabetic neuropathy and measures average pain intensity over 24 weeks.[1] Sodium Chloride is used as the placebo comparison in this Phase 2 study.[1]
The TICH-3 trial studies tranexamic acid in stroke caused by intracerebral haemorrhage and uses Sodium Chloride Injection as the comparison treatment.[1] The main outcome is early death within 7 days after the bleed.[1]
The LOTUS, LIVER AKI, and TICH-3 studies show how Sodium Chloride is often used to help compare a new treatment against a neutral control in serious hospital conditions.[1]
What this means for patients
If you see Sodium Chloride in a trial record, it often means the study is comparing a new treatment against a standard neutral option.[1] This makes it easier to know whether the active treatment really helps.[1]
These trials do not all study the same illness, so the meaning of participation depends on the condition, age group, and treatment plan in that specific study.[1] Some trials are short and focus on immediate outcomes, while others follow people for months or even years.[1]
